KY HB423 | 2020 | Regular Session
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 12 2020 - 25% progression, died in committee
Action: 2020-02-14 - to Banking & Insurance (H)
Pending: House Banking and Insurance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 12 2020 - 25% progression, died in committee
Action: 2020-02-14 - to Banking & Insurance (H)
Pending: House Banking and Insurance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Create a new section of Subtitle 17A of KRS Chapter 304 to define terms; prohibit certain conduct of health plans and pharmacy benefit managers related to the coverage of certified insulin; provide a process by which manufacturers may have an insulin product determined certified insulin; impose requirements on the commissioner relating to the certification of an insulin product; provide short title.
Title
AN ACT relating to the cost of insulin.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2020-02-14 | House | to Banking & Insurance (H) |
2020-02-12 | House | introduced in House |
Subjects
Drugs and Medicines
Health Benefit Mandate
Insurance, Health
Short Titles and Popular Names
State Agencies
Health Benefit Mandate
Insurance, Health
Short Titles and Popular Names
State Agencies
Kentucky State Sources
Type | Source |
---|---|
Summary | https://apps.legislature.ky.gov/record/20RS/hb423.html |
Text | https://apps.legislature.ky.gov/recorddocuments/bill/20RS/hb423/orig_bill.pdf |